Patient costs for drug-resistant TB diagnosis and pre-treatment evaluation in North India
Despite free diagnosis and treatment, a significant portion of DR-TB households in India incur catastrophic costs, mainly from indirect expenses, indicating a need for targeted policy and programme interventions.
Authors
- A. Krishnan (ORCID: https://orcid.org/0000-0003-1504-3129)
- Surya Kant (ORCID: https://orcid.org/0000-0001-7520-5404)
- A. Mohan (ORCID: https://orcid.org/0000-0003-3887-8321)
- Sudip Das (ORCID: https://orcid.org/0000-0002-8372-4316)
- Raj Kumar
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Public Health Action
- Published
- 2024-09-01
- DOI
- https://doi.org/10.5588/pha.24.0018
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00